91桃色

   Return to Policies
   Print Policy No:
Return to Policies Print Policy No:
91桃色 Logo     
Policy No: 2067
Responsible Office: Research Compliance and Assurance
Last Review Date: 04/28/2022
Next Required Review: 04/28/2027
Policy No: 2067
Responsible Office: Research Compliance and Assurance
Last Review Date: 04/28/2022
Next Required Review: 04/28/2027

Conflict of Interest in Research

1. Purpose

This policy establishes 91桃色 guidelines to aid in the identification, evaluation and resolution of potential or real Financial Conflict of Interest related to University research activities. This Policy is intended to establish compliance with the rules adopted effective September 26, 2011 by the U.S. Public Health Service, Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought [] and the Chapter V: Grantee Standards, Policies and Procedures Guide. These agencies require that grantee institutions adopt, maintain and enforce written policies pertaining to researchers' financial conflicts of interest.

While not addressed by this policy, the Alabama State Ethics Law, as well as other laws, regulations or policies, may also specifically define and limit the ability of Employees of the University to participate in certain activities. The University and its Employees are also subject to the provisions of the Code of Ethics for Public Officials, Employees, etc. as described in Chapter 25 of the Title 36, Code of Alabama, 1975 (the Alabama State Ethics Law). Therefore, it is the policy of the University that Employees of the University demonstrate, in all professional and research activities, that their primary obligation is to the University and the integrity of the research and that they adhere, in all instances, to the highest standards of ethical behavior.

2. Applicability

Conflict of Interest in Research policy applies to:

2.1  University employees (i.e., faculty, staff, students, trainees) who are responsible for the design, conduct, or reporting of research and scholarly activities* and any University faculty who are identified in a budget or who are acting as a consultant or collaborator in any:

2.1.1  Externally supported activities for University programs, projects, activities and services;

2.1.2  Internally supported research activities for the benefit of an external entity (e.g. non-funded research projects where deliverables such as reports/data are provided to an external entity).

2.2  University faculty, staff or students who hold a financial interest or obligation in a company that is negotiating an agreement with the Office of Commercialization and Industry Collaboration for technology developed by the respective faculty, staff or student.

*Exceptions:

Not included: Individuals who do not make independent decisions regarding the design, conduct, or
reporting of the activity in question, and only work on or are engaged in the activity (for example, in
most cases research assistants, undergraduate students and administrative support will not be considered responsible for the design, conduct, or reporting of activities of a research project). However, for PHS funded activities: collaborators or consultants are considered responsible for the design, conduct, or reporting of activities of a research project. For review and management of conflicts, the governing legal and policy requirements shall prevail.

3. Definitions

Business Entity: A Business Entity is defined as any corporation, partnership, sole proprietorship, firm, franchise, holding company, joint-stock company, receivership, real estate trust, or other legal entity organized for profit and non-profit entities that may provide support to employees as salary, consulting, or board compensation. The term does not include the University or any other entity controlled by the University. Business Entity does not include federal, state, or local government agencies, institutions of higher education as defined at 20 U.S.C. 1001(a), academic teaching hospitals, medical centers, or research institutes affiliated with an institution of higher education.

Clinical Research: Any study, regardless of funding source, involving the evaluation of a diagnostic or therapeutic drug, a vaccine, or a medical device in preparation for a regulatory evaluation or within a regulatory evaluation process, when the protocol requires approval by the Institutional Review Board of the 91桃色.

Compensation: anything of economic value, however designated, which is paid, loaned, granted, given, donated, or transferred to any person from any Business Entity for or in consideration of personal services, materials, property, or the like. Compensation does not include:

    • Salary, royalties, or other remuneration paid by the University to an Investigator or Innovator if the Investigator or Innovator is currently employed by or has an academic appointment at the University;
    • Payments or the entitlement to payments from the University derived from royalties and fees paid to the University by a third-party for Intellectual Property assigned by an Investigator or Innovator to the University;
    • Income from investment vehicles, such as mutual funds and retirement accounts, providing the Investigator or Innovator does not directly control the investment decisions made by such vehicles;
    • Income from seminars, lectures, or teaching engagements sponsored by the University, a federal, state, or local government agency, an Institution of Higher Education, an academic teaching hospital, a medical center, or a research institute that is affiliated with an Institution of Higher Education; or
    • Income from service on advisory committees or review panels for the University, a federal, state, or local government agency, an Institution of Higher Education, an academic teaching hospital, a medical center, or a research institute that is affiliated with an Institution of Higher Education.
  •  
  • Conflict of Interest:

Financial Interest: Compensation received from external sources to include the following examples:

      • Anything of monetary value including, but not limited to, salary, royalties, or other payments for services, including payments for consulting services and services on advisory committees;
      • Intellectual Property Rights including named inventor on a patent/patent assignee, copyrighted material and benefits accruing from such rights;
      • Equity interests; e.g., owning or having the right or obligation to acquire stocks or stock options or other securities in a business entity;
      • Position in a non-91桃色 entity giving rise to a fiduciary duty such a as consultant, employee, director, or any position of management;
      • Investigators with funding from the Public Health Service, any sponsored or reimbursed travel (this excludes travel sponsored/reimbursed by government agencies, academic medical centers, public/non-profit institutions of higher education, or their affiliated research institutes);
      • Examples of “Financial Interest” do not include compensation received from the University;
      • Salary, share in royalties in accordance with University policy, or other remuneration from 91桃色 (91桃色);
      • Intellectual property rights developed in the course of employment at 91桃色 and assigned to 91桃色.

Financial Conflict of Interest: A Financial Conflict of Interest arises when an Employee is in a position to benefit personally from or to influence either directly or indirectly University business, research, or other decisions in ways that could lead to gain for the Employee, the Employee's family, or others. While financial interests should not and, in most cases, do not, compromise intellectual honesty or institutional integrity, under federal law and according to 91桃色 policy, they must not have the appearance of compromising the University's values and missions of teaching, research, and public service. Any financial conflict of interest (real or apparent) should be disclosed so it can be managed, reduced or eliminated in accordance with federal regulations and the terms of this policy.

Significant Financial Interest: anything of monetary value that does or could reasonably be perceived to directly and significantly affect the design, conduct, or reporting of funded research, or the performance of other Institutional Responsibilities, whether or not the value is readily ascertainable.* For purposes of disclosure, Investigators and Employees must disclose their own financial conflict of interests, as well as their family member’s financial conflict of interest.

* Note: “Significant” in “Significant Financial Interest” (a term used in the PHS Conflict of Interest Regulations) refers to the potential that the financial interest could affect the design, conduct or reporting of research, not to the dollar value of the financial interest. The University has established a zero dollar threshold for reporting both in dollar value and in percentage of equity holding, meaning that if the financial interest could reasonably be perceived to directly and significantly affect the research it must be reported even if its dollar value or percentages is de minimus.

Conflict Management Plan: a written plan instituted by the University for the management, reduction or elimination of a Financial Conflict of Interest.

Consulting: for purposes of this policy, includes but is not limited to the provision of information and expertise on professional matters and the holding of extramural management positions and/or board memberships.

Disclosure Form: is the personal financial information provided by an Investigator or Employee which shall include a complete description, including dollar amounts or percentages of ownership, for all Significant Financial Interests related to their professional responsibilities to the University.

Employee: for the limited purposes of this Policy, any individual who is employed by the University, whether full or part time, and includes but is not limited to staff, faculty, postdoctoral fellows, medical house staff, educational trainees and students.

Family Member: Includes spouse, son/daughter, grandson/granddaughter, parent, grandparent, sibling, niece, nephew, aunt, uncle, cousin, and in-laws or step relations in those capacities; any person living in the member’s household; any person, regardless of their legal residence or domicile who receives 50% or more of their support from the member (or member’s spouse); or any person who resided with the member (or their spouse) for more than 180 days over the past year.

Foreign Component: Performance of any significant element or segment of the project outside the United States, either by the grantee or by a researcher employed by a foreign institution.

Foreign Support: Resources made available to a researcher in support of and/or related to all of their research endeavors. This includes resources of both monetary and non-monetary value, and is regardless of whether the resources are based at 91桃色 or another institution.

Human Subjects Research: is any research that has been designated “human subjects research” by the University’s Institutional Review Board.

Institutional Responsibilities: the Investigator’s responsibilities associated with his or her Institutional appointment or position, such as research, teaching, and service activities, administration, and institutional, internal and external professional committee service. Intellectual Property. Intellectual Property Rights are defined as all products of the human intellect that receive legal protection through patent, copyright, trademark or trade secret law developed by Employees that are owned in whole or part by the University, its affiliated foundations according to the University Patent and Invention Policy or by an individual.

Investigator: an individual, regardless of whether or not an Employee of the University as defined in this Policy, who is the project director or the principal Investigator and any other person, regardless of title or position, who is responsible for the design, conduct or reporting of research or scholarly activities conducted in whole or in part under the auspices of the University, which may include for example, collaborators, consultants and/or subaward or subcontract recipients.

University: which may include for example, collaborators, consultants and/or subaward or subcontract recipients.

Key Personnel: Senior/key personnel are considered to be individuals who have the authority to make independent decisions about the direction of the research and the subsequent conclusions about the results. This does not include administrative personnel or individuals who perform routine, pre-defined, or incidental tasks related to the project. Key personnel must disclose their financial interest to the University. NOTE: Staff, postdoctoral fellows who assume independent responsibility for portions of an Investigator’s proposed or funded PHS or NSF project are required to meet disclosure requirements of this Policy.

Manage: Taking action to address a financial conflict of interest which can include reducing or eliminating the conflict to ensure that the design, conduct and reporting of research are free from bias. Generally a financial conflict of interest is handled through a Management Plan.

PHS: the Public Health Service of the U.S. Department of Health and Human Services and any PHS awarding components to which authority may be delegated, including without limitation the National Institutes of Health.

PHS-Funded Investigator: an Investigator applying for or participating in any PHS-Funded Research. For the avoidance of doubt, PHS-Funded Investigator includes an Investigator applying for or participating in both PHS-Funded Research and non-PHS-Funded Research.

PHS-Funded Research: any Research or sponsored activity for which funding is available from a PHS awarding component through a grant or cooperative agreement, however authorized, such as a research grant, career development award, center grant, individual fellowship award, infrastructure award, institutional training grant, program project, or research resources award. Notwithstanding the foregoing, PHS-Funded Research does not include any Phase I SBIR Program application or award.

Research: a systematic investigation, study or experiment designed to develop or contribute to generalizable knowledge. The term includes, but is not limited to, basic and applied research (e.g., a published article, book or book chapter) and product development.

University: is defined to mean all units of the 91桃色, including schools, colleges, hospitals, clinics, health system affiliates and any other components not otherwise listed.

4. Policy Guidelines

“Significant” in “Significant Financial Interest” (a term used in the PHS Conflict of Interest Regulations, 42 CFR Part 50) refers to the potential that the financial interest could affect the design, conduct or reporting of research, not to the dollar value of the financial interest.

The University has established a zero dollar threshold for reporting in both the dollar value and in percentage of equity holding, meaning that if the financial interest could reasonably be perceived to directly and significantly affect the research it must be reported even if its dollar value or percentages is minimal.

Specifically:

  • Investigators and key personnel are responsible for identifying and disclosing actual or potential conflicts covered by this policy. Investigators and/or research personnel should evaluate potential conflicts of interest not only at the outset of their research, but also when a change occurs in their relationship with an outside entity. This may occur at the time a new proposal is submitted, when a new relationship is established with an outside entity, or when a prior relationship with an outside entity changes;
  • Investigators and key personnel are responsible for updating their disclosures whenever there is a change to the information contained in the initial disclosure;
  • When mandated by a research sponsor (e.g., the Department of Health and Human Services [HHS]), investigators must submit an annual disclosure of financial interests related to their institutional responsibilities (regardless of whether the interest creates a conflict of interest in research), in accordance with the schedule established by the university. The university may also require disclosures at other times. Investigators who are seeking support from HHS must have a current annual disclosure at the time of proposal submission. Investigators with HHS sponsored funding must update their
    annual disclosures within 30 days of the time they obtain a financial interest with an entity that was not disclosed at the time of the most recent annual disclosure. All changes to financial interests with entities disclosed in the annual disclosure must be updated at the time of the next annual disclosure;
  • Investigators are not permitted to begin any research activity when they have reported an actual or apparent conflict of interest before they receive a written determination from the Office of Research Compliance as to how to manage the conflict. Investigators also are not permitted to begin an external activity that would create a conflict of interest relative to an ongoing research activity before they receive a written determination from the Office of Research Compliance as to how to manage the
    conflict;
  • Investigators and key personnel must provide timely and accurate information in response to the Office of Research Compliance and other administrative offices in order for an initial determination regarding the disclosure and/or to monitor their compliance with the management plan;
  • Investigators and key personnel must comply with all of the elements of the conflict of interest management plan, as approved by the Office of Research Compliance and the Vice President for Research and Economic Development;
  • All investigators must complete training relating to conflicts of interest in research as prescribed by the university;
  • Each investigator is responsible for confirming that research personnel under his or her supervision who are involved in proposing, conducting or reporting research on the investigator’s project identify and disclose any potential conflict of interest;
  • Prohibited conflicts are not acceptable and, therefore, should not occur. Immediate
    action must be undertaken to eliminate any prohibited conflict.

4.1  Activities Requiring Disclosure

The activities listed under this heading suggest a possibility of conflicting loyalties that can impair objectivity, but disclosure and resulting analysis of relationships may render the activity permissible.

4.1.1  Research and Scholarly Activity
Disclosure is required when an Employee is responsible for the approval, design, conduct, or reporting of sponsored research conducted in whole or in part under the auspices of the University.

4.1.1.1  Employees. Disclosure is required when an Employee or his/her Family
Member has a Significant Financial Interest related to research or scholarly activities involving University subordinates or students and the Employee has responsibility for the subordinates’ or students’ employment and/or academic evaluations.

4.1.1.2  Other individuals. Disclosure is required when a student or postdoctoral scholar or his/her Family Member has a Significant Financial Interest and submits an individual application for fellowship or other research support under the auspices of the University.

For each proposed research activity, Principal Investigators are responsible for determining which faculty, staff, students, and trainees meet the definition of “investigator” defined above. When submitting a grant proposal, named “investigators” are required to submit a Financial Conflict of Interest Certification form and if necessary, a disclosure form.

4.1.2  Foreign Engagement
Participation in a foreign government talent recruitment program, or any similar program designed to acquire US scientific funded research, must be disclosed to federal sponsors and the University. 91桃色 researchers should also reach out to 91桃色’s Director of Information Security and Risk Compliance (dfurman@southalabama.edu) to discuss such activity, even if they’ve previously disclosed their participation to other 91桃色 officials.  Depending on an individual’s research portfolio, he/she may be advised to terminate his or her affiliation with the foreign talent program.

Additionally, any foreign support or engagement that you would acknowledge in presentations or publications is something that must be disclosed in university-related conflict of interest and/or external professional activities forms.  Foreign components involved in federally-funded research should be disclosed on proposals, progress reports, and final technical reports.

4.1.3  Human Subjects Research
Disclosure is required to the IRB when an Investigator is responsible for the design, conduct, or reporting of human subject’s research conducted in whole or in part under the auspices of the University. The disclosure is required of the Principal Investigator, each co-investigator and any other person responsible for designing research, directing research, enrolling research subjects, obtaining subjects’ informed consent, making decisions related to eligibility to participate in research or analyzing or reporting research data.

4.1.4  Consulting
In instances where an employee’s external consulting, with or without compensation, could reasonably pose a conflict of interest, the employee is required to disclose the activity.

4.1.5  Intellectual Property
Disclosure is required prior to the negotiation of any licensing agreements when an Employee is a named inventor on an invention disclosure and the Employee or his/her Family Member has a Significant Financial Interest in a Business Entity related to the Intellectual Property.

4.1.6  Faculty Use of Students in Outside Professional Activities
The 91桃色 recognizes that the involvement of students in faculty-owned or managed companies or consulting may provide considerable benefit to the student, as long as certain conditions are met.

      • Faculty must disclose the proposed involvement of students in their external activities or in company-sponsored research;
      • Faculty who anticipate serving as PI or co-PI on sponsored projects and have
        graduate students or trainees conduct part of the research under their oversight must develop a conflict of interest management plan addressing protections and ensure activities do not interfere with their academic progress;
      • Students and postdoctoral trainees should be informed about the source of their funding, the researcher’s personal interest and/or involvement with external activities, and if applicable, any agreement concerning copyright, data collection, or patents resulting from the research.

4.1.7  Training and Travel Reporting Requirements for PHS Funded Investigators

Training - Prior to engaging in PHS-funded research or with a non-PHS organization compliant with PHS COI regulations, and no less often than every four (4) years, all PHS-Funded Investigators must complete training with respect to this Policy and the then-current PHS FCOI rules and regulations. This requirement also applies to any sponsor in addition to PHS that requires training prior to engaging in research.

Travel - PHS-Funded Investigators and investigators funded by sponsors requiring travel disclosures must disclose the occurrence of any reimbursed or sponsored travel related to their Institutional Responsibilities unless the travel was sponsored or reimbursed by the University.

4 .2  Prohibited Activities

The activities cited below involve scenarios that are not generally permissible because they involve potential Financial Conflicts of Interest. Before proceeding with these activities, the Employee must have approval from the appropriate Vice President.

4.2.1  Secrecy or confidentiality requirements are not allowed if they impact evaluation of a student, faculty member, or other Employee, or if they delay fulfillment of degree requirements by more than the time contractually allowed for publication and/or protection of intellectual property rights (up to 6 months).

4.2.2  Investigators shall not permit a sponsor to compromise the integrity of the scientific analysis or the publication of research results or its conclusions.

4.2.3  Evaluation of faculty, staff, postdoctoral fellows, medical house staff, educational trainees or students is not allowed to be based, in whole or in part, on participation in (or refusal to participate in) non-University activities involving Business Entities in which the evaluating Employee or Investigator has a Significant Financial Interest.

4.2.4  Individual Investigators or Employees participating in the design, conduct or reporting of a human subjects research study, or their Family Members, shall not, directly or indirectly, accept any incentives or gifts from a Business Entity that is sponsoring or providing support for the study.

4.2.5  Involvement by an Employee in the process of negotiating a license on behalf of the University with a Business Entity in which the Employee or his/her Family Member has a Significant Financial Interest is not allowed.

4.3  Sub-recipient Compliance and Reporting

The University must apply relevant originating sponsor conflict of interest requirements to sub-recipients. Thus, the University must identify whether or not a sub-recipient has a conflict of interest policy compliant with applicable originating sponsor conflict of interest requirements. The Office of Sponsored Projects Administration collects the following at time of proposal submission: See “Sub-recipient Compliance and Reporting” in the Conflict of Interest in Research Procedures for additional information.

4.4  Training

Investigators engaged in PHS-funded research or with a non-PHS organization compliant with PHS COI regulations are required to complete training regarding their responsibilities under this Policy prior to engaging in any PHS-funded research project and at least every 4 years.  In addition, Investigators must complete such training immediately if 91桃色 finds that the Investigator is not in compliance with this Policy or a management plan adopted thereunder. 

4.5  Confidentiality

Conflict of interest disclosures and determinations concerning conflicts and violations shall be available to:

4.5.1  The Investigator or Employee’s University superiors;

4.5.2  The appropriate University offices, including but not limited to, the Office of the Vice President for Research, the Office of General Counsel, Internal Audit, Institutional Review Board, Sponsored Projects Administration, Office of Intellectual Property Management, and other Employees whose responsibilities to the University are directly affected by the conflict of interest. In certain circumstances, federal and state law may require public disclosure of information relating to identified conflicts of interest.

4.5.3  In other circumstances, including but not limited to conflicts regarding human subject’s research, the University may require public disclosure as part of a conflict management plan.

4.5.4  Any information disclosed by an Investigator or Employee as required by this Policy shall be used solely for the purpose of administering this Policy and shall not be used for any other purpose unless required by law. Unauthorized disclosure of any such information by an Employee shall be deemed to be unethical behavior and shall be punishable under pertinent University
Regulations.

4.6  Administrative Actions, Penalties, and Reports of Violations

4.6.1  Reports of violations of this policy, such as failure to disclose financial interests, failure to update financial conflict of interests or failure to comply with prescribed management plans, must be reported to the Director, Office of Research Compliance.

4.6.2  The Vice President for Research or appropriate Vice President(s) shall investigate all potential non-compliance with this Policy, including potential non-compliance with prescribed management plans. During the investigation, the individual’s supervisor will review the report of violation, any response, and any other relevant documentary material.

4.6.3  Protection of affected parties is required, to the extent permitted by law and University policies. The University will protect the identity and privacy of those individuals who, in good faith, report apparent non-compliance with this Policy or furnish information regarding such non compliance. Retaliation of any kind against any individual, who, in good faith, alleges non compliance or cooperates with the investigation, is prohibited and the retaliator may be subject to discipline under pertinent University policies.

4.7  Appeals

Any decision concerning the existence of a conflict of interest or the appropriateness of a plan to manage, reduce, or eliminate a conflict may be appealed within thirty (30) days to a panel which shall include the Senior Vice President for Academic Affairs or the Vice President for Medical Affairs and the Vice President for Research and Economic Development. The decision of the panel shall be final.

4.8  Institutional Reporting and Record Retention

The Office of Research Compliance shall be responsible for maintenance of all records that meet the requirements of 42 CFR Part 50 Subpart F:

4.8.1  All disclosures and management plans and related information must be retained for a minimum of three years from the date of the final expenditure report on a grant or contract or three years from the date of project completion when no final expenditure report is required.

4.8.2  All other dates specifies in 45 CFR 74.52(b) and 92.42(b) when applicable for federal funds.

4.9  Public Accessibility

This policy and each update of this policy will be publicly accessible on the 91桃色’s website. Additionally, the Institution will make available by written response to any requestor within five business days information regarding specified financial conflict of interest related to PHS funded research. Disclosed information will be provided to the extent required by applicable PHS regulations and state law.

4.10  Retrospective Review and Reporting

In cases where a financial conflict of interest is not identified or managed in a timely manner, retrospective review and reporting is required for PHS-funded research or Non-PHS organizations that require compliance with PHS Financial Conflict of Interest Regulations.

The institution has 60 days to determine if a conflict of interest exists and implement a management plan if needed. Additionally, if a conflict of interest is identified as it was not managed due to noncompliance by the Investigator, the Institution has 120 days from the date of noncompliance was identified to conduct a retrospective review of the Investigator’s activities and the research project to assess if any bias in the design, conduct, or reporting of the research as a result.

5. Procedures

The Conflict of Interest in Research Procedures (see link in Section 7 of this policy) must be followed to ensure compliance with this policy. The Procedures supplement this Policy and apply to all sponsored research subject to
Public Health Service and National Science Foundation regulations, and other research activities
involving potential conflict of interest.

6. Enforcement

For violations of this Policy, one or more of the following restrictions may include, but not limited to:

  • Freeze research funds, or otherwise suspend, a project or projects related to the policy violation;
  • Remove the individual found to be in violation from a role as Principal Investigator or Investigator on a project or projects related to the policy violation;
  • Prohibit submission of new applications to the Institutional Review Board and/or Sponsored Projects Administration until resolution of the relevant conflict of interest issues or for a specified period of time;
  • Notification to funding agencies and/or professional journals;
  • Letter of reprimand; and/or
  • Reassignment of duties

The individual Investigator or Employee may appeal the restriction(s) to a panel which shall include the Senior Vice President for Academic Affairs, the Vice President for Medical Affairs, and the Vice President for Research and Economic Development. The decision of the panel shall be final.

In situations involving the health or safety of any person or the potential loss of significant University resources, the panel may implement any restrictions that are necessary to protect these persons and resources pending the outcome of the investigation. Otherwise, no restrictions, disciplinary or administrative action shall occur until the conclusion of the violation evaluation process set forth in this Policy.

7. Related Documents

7.1  91桃色 Related Documents:

Conflict of Interest in Research Procedures

Conflict of Interest and Conflict of Commitment Policy

External Professional Activities Policy

PHS and Non-PHS Organizations Requiring Compliance with COI Regulations

Guidance for Determining if a Financial Conflict of Interest is Related to PHS-Funded Project

PHS Subrecipient instructions and disclosure forms

Notification letter informing students/staff of potential conflict of interest

7.2  Related Regulations:

2011 Public Health Service (PHS) Regulations: Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought (

, Chapter V: Grantee Standards